Join the Mild Cognitive Impairment group to help and get support from people like you.
Mild Cognitive Impairment News
Related terms: MCI, Cognitive Impairment
Psychotherapy Might Be Key Treatment For Low Back Pain
TUESDAY, Aug. 12, 2025 — A type of psychotherapy appears to provide long-lasting relief for people suffering from chronic low back pain, a new clinical trial says. Back pain patients who underwent c...
Metformin Use Tied to Lower Risk for Dementia, Death in Adults With Overweight, Obesity
TUESDAY, Aug. 12, 2025 – Metformin use is associated with lower risks for dementia and all-cause mortality across body mass index (BMI) groups in patients with overweight or obesity, according to a...
Tiny Traces of Lithium May Help Protect the Brain From Alzheimer’s
FRIDAY, Aug. 8, 2025 — Tiny amounts of lithium — a natural metal — may help protect the brain from Alzheimer’s and signs of aging, new research shows. Scientists at Harvard Medical School and Rush Uni...
Cognitive Functional Therapy Effective for Chronic Low Back Pain at Three Years
WEDNESDAY, Aug. 6, 2025 – Cognitive functional therapy (CFT), with or without biofeedback, is more effective than usual care for treating patients with chronic disabling low back pain, according to...
Average Time to Diagnosis Is 3.5 Years Across All Types of Dementia
FRIDAY, Aug. 1, 2025 – The mean time to diagnosis (TTD) for dementia is 3.5 years across all types of dementia, according to a review published online July 27 in the International Journal of...
Intranasal Administration of PET Radiotracer Delivers Insulin to Multiple Brain Regions
THURSDAY, July 31, 2025 – Intranasal administration of [68Ga]Ga-NOTA-insulin is safe and delivers insulin to multiple brain regions, according to a study published online July 23 in Alzheimer's &...
Over 60? Healthy Lifestyle Change May Help Boost Your Brain
WEDNESDAY, July 30, 2025 — Two years’ involvement in programs focused on healthy eating, regular exercise and “brain training” exercises appears to have helped a wide range of older adults — even thos...
Lifestyle Interventions Improve Cognition for At-Risk Older Adults
WEDNESDAY, July 30, 2025 – Lifestyle interventions improve cognition for older adults at risk for cognitive decline and dementia, with significant benefit seen for a structured intervention,...
Dementia Diagnosis Typically Comes 3.5 Years After Symptoms
TUESDAY, July 29, 2025 — It takes an average of three-and-a-half years for typical dementia symptoms to lead to a diagnosis, a new report finds. Diagnosis often comes even later for early-onset d...
Long-Term Exposure to Air Pollution Tied to Higher Risk for Dementia
TUESDAY, July 29, 2025 – Long-term exposure to outdoor air pollution may increase the risk for dementia, according to a review published online July 24 in The Lancet Planetary Health. Clare B. Best ...
Insulin Nasal Spray Reaches Alzheimer's Targets, Brain Scans Show
THURSDAY, July 24, 2025 — Insulin delivered by nasal spray might be a potential treatment for Alzheimer’s disease, a new study says. An insulin nasal spray effectively reached key memory regions in th...
The Many Faces of Parkinson’s: Symptoms, Treatment, and How To Manage It
THURSDAY, July 24, 2025 — About 90,000 people are diagnosed with Parkinson’s disease (PD) each year – one person every six minutes. While most people associate PD with tremors and stiffness, the condi...
GLP-1 Receptor Agonists Tied to Decrease in T2DM-Related Dementia Risk
WEDNESDAY, July 23, 2025 – Glucagon-like peptide 1 receptor agonists (GLP-1 RAs) are associated with reduced type 2 diabetes mellitus (T2DM)-related dementia risk compared with metformin, according...
Risk for Dementia, Ischemic Stroke, Mortality Lower With GLP-1 Receptor Agonists in T2D, Obesity
TUESDAY, July 22, 2025 – For adults with type 2 diabetes and obesity, glucagon-like peptide 1 receptor agonists (GLP-1 RAs) are associated with a lower risk for dementia, stroke, and all-cause...
Dementia Risk Does Not Differ With GLP-1 RAs, DPP4is for Seniors With T2DM
MONDAY, July 21, 2025 – For older adults with diabetes, there is no clear evidence to suggest that the incidence of dementia differs for those using glucagon-like peptide 1 receptor agonists (GLP-1...